Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL27819038 | 1.00 | NAPRT (0.69) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL2077502 | 1.00 | NAPRT (0.69) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL39580 | 1.00 | NAPRT (0.69) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL21044758 | 0.96 | TSHR (0.64) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL28091895 | 0.96 | TSHR (0.64) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL27444871 | 0.96 | TSHR (0.64) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL28773703 | 0.87 | TSHR (0.53) | NAPRTTSHRTDP1SLC6A3 | |
| Pyridine SCHEMBL11789826 | 0.86 | NAPRT (0.60) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL27344156 | 0.86 | TSHR (0.60) | NAPRTTSHRTDP1NOTUMSLC6A3 | |
| Pyridine SCHEMBL17688281 | 0.86 | NAPRT (0.60) | NAPRTTSHRTDP1NOTUMSLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773908-B1 | BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION | SAMYANG BIOPHARMACEUTICALS (KR) | 2012-09-19 | — | — | EP | claimed |
| US-7655735-B2 | Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same | SAMYANG CORPORATION (KR) | 2010-02-02 | — | — | US | claimed |
| JP-2008508414-A | — | — | 2008-03-21 | — | — | JP | claimed |
| US-20070161753-A1 | Biodegradable multi-block polymeric composition capable of sol-gel trainsition and pharmaceutical composition comprising the same | SAMYANG HOLDINGS CORPORATION (KR) | 2007-07-12 | — | — | US | claimed |
| EP-1773908-A1 | BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION | Samyang Corporation (KR) | 2007-04-18 | — | — | EP | claimed |
| WO-2006014067-A1 | BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION | SAMYANG CORPORATION (KR) | 2006-02-09 | — | — | WO | claimed |
| CN-105873930-B | Novel bicyclic compounds and their use as antibacterial agents and β -lactamase inhibitors | 费多拉制药公司 | 2019-02-19 | — | — | CN | disclosed |
| CN-105873930-A | Novel bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors | 费多拉制药公司 | 2016-08-17 | — | — | CN | disclosed |
| EP-1773908-B1 | BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION | SAMYANG BIOPHARMACEUTICALS (KR) | 2012-09-19 | — | — | EP | disclosed |
| US-7655735-B2 | Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same | SAMYANG CORPORATION (KR) | 2010-02-02 | — | — | US | disclosed |
| US-20070161753-A1 | Biodegradable multi-block polymeric composition capable of sol-gel trainsition and pharmaceutical composition comprising the same | SAMYANG HOLDINGS CORPORATION (KR) | 2007-07-12 | — | — | US | disclosed |
| EP-1773908-A1 | BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION | Samyang Corporation (KR) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014067-A1 | BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION | SAMYANG CORPORATION (KR) | 2006-02-09 | — | — | WO | disclosed |
| US-5721226-A | Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives | MAGAININ PHARMACEUTICALS INC. (US) | 1998-02-24 | — | — | US | disclosed |
| US-5637691-A | STEROIDS HAVING POLYAMINE SIDE CHAIN; BACTERICIDES, FUNGICIDES, ANTIPROTOZOA AGENTS | MAGAININ PHARMACEUTICALS, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| EP-0749437-A1 | STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR PHARMACEUTICAL USES | MAGAININ PHARMACEUTICALS INC. (US) | 1996-12-27 | — | — | EP | disclosed |
| EP-0688333-A1 | STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE AS ANTIBIOTICS OR DISINFECTANTS | MAGAININ PHARMACEUTICALS INC. (US) | 1995-12-27 | — | — | EP | disclosed |
| WO-1995024415-A1 | STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR PHARMACEUTICAL USES | MAGAININ PHARMACEUTICALS INC. (US) | 1995-09-14 | — | — | WO | disclosed |
| WO-1994020520-A1 | STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE AS ANTIBIOTICS OR DISINFECTANTS | MAGAININ PHARMACEUTICALS INC. (US) | 1994-09-15 | — | — | WO | disclosed |
| US-4264578-A | STEROL SULFATE SALTS IN SILICONE RUBBER MATRIX FOR UTERINE INSERTS | ELI LILLY AND COMPANY (US) | 1981-04-28 | — | — | US | disclosed |